Celyad Oncology SA
XBRU:CYAD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Celyad Oncology SA
XBRU:CYAD
|
BE |
|
E
|
Exmar NV
XBRU:EXM
|
BE |
|
P
|
Primex Corp
XPHS:PRMX
|
PH |
Shareholder Yield
Current shareholder yield for
CYAD is
.
Peers Comparison
Shareholder Yield
Price Appreciation
CYAD Price
Celyad Oncology SA
| Average Annual Return | -14.53% |
| Standard Deviation of Annual Returns | 71.19% |
| Max Drawdown | -96% |
| Market Capitalization | 9.8m EUR |
| Shares Outstanding | 47 260 000 |
| Percentage of Shares Shorted |
N/A
|